Form 8-K - Current report:
SEC Accession No. 0001558370-22-018412
Filing Date
2022-12-07
Accepted
2022-12-06 17:39:17
Documents
13
Period of Report
2022-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20221130x8k.htm   iXBRL 8-K 45312
2 EX-10.1 cydy-20221130xex10d1.htm EX-10.1 123435
  Complete submission text file 0001558370-22-018412.txt   289447

Data Files

Seq Description Document Type Size
3 EX-101.SCH cydy-20221130.xsd EX-101.SCH 3050
4 EX-101.LAB cydy-20221130_lab.xml EX-101.LAB 14193
5 EX-101.PRE cydy-20221130_pre.xml EX-101.PRE 9292
7 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20221130x8k_htm.xml XML 4347
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 221448616
SIC: 2834 Pharmaceutical Preparations